Award-winning Alflorex contains the unique B. infantis 35624 strain of ‘good bacteria’. Developed by PrecisionBiotics, this member of the Bifidobacterium family occurs naturally in the human digestive system and is contained in breastmilk, thus indicating its importance in gut health. It's precision formulation ensures that it transits to the gut intact, ready to deliver the benefits of around 1 billion live bacteria per capsule.
B. infantis 35624 has undergone rigorous scientific testing and human clinical trials by the Alimentary Pharmabiotic Centre in Co. Cork, one of the world’s leading authorities on microbiome research and gut health and is especially beneficial in assisting those with Irritable Bowel Syndrome.
Irritable Bowel Syndrome affects around 10 - 15% of the European population. With often intractable symptoms and lack of efficacy in conventional treatments, it is a debilitating condition. The probiotic strain B. infantis 35624 contained in Alflorex has been shown to greatly alleviate symptoms when compared with other strains of bacteria. B. infantis 35624 aids the reduction of intestinal inflammation, therefore, relieving symptoms of IBS such as abdominal pain and discomfort, bloating, cramps, and changes in bowel movement.